We present the case of a 66-year-old female diagnosed with gallbladder cancer that was initially discovered with contrast enhanced computed tomography. The primary gall bladder tumor displayed heterogeneous enhancement. The patient underwent cholecystectomy with full-thickness excision of the gallbladder cancer. After 3 rounds of adjuvant chemotherapy with the oral fluoropyrimidine derivative, S-1 (administered for 4 weeks at 120 mg/day and then stopped for 2 weeks), a metastasis measuring 15 mm in diameter emerged within hepatic segment 5. The chemotherapy regimen was altered to include 6 months of combination therapy with gemcitabine (1,000 mg/m') and cisplatin (25 mg/m2) given once every week for 2 weeks and then stopped for 1 week. The hepatic metastasis decreased in size to 8 mm in diameter, and a partial liver resection was performed. After hepatectomy, the patient remains alive and without disease recurrence. Key words: Liver metastasis of gallbladder cancer, Chemotherapy, Metachronous liver metastasis (Received Mar. 9, 2020/Accepted May 13, 2020).
|ジャーナル||Japanese Journal of Cancer and Chemotherapy|
|出版ステータス||Published - 10-2020|
All Science Journal Classification (ASJC) codes